1
|
Alonso SP, Valdés S, Maldonado-Araque C, Lago A, Ocon P, Calle A, Castaño L, Delgado E, Menéndez E, Franch-Nadal J, Gaztambide S, Girbés J, Chaves F, Garcia-Serrano S, Garcia-Escobar E, Fernandez-García JC, Olveira G, Colomo N, Rojo-Martínez G. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study. Eur J Endocrinol 2021; 186:95-103. [PMID: 34735370 DOI: 10.1530/eje-21-0640] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Accepted: 11/04/2021] [Indexed: 11/08/2022]
Abstract
OBJECTIVE It has been proposed that a mild form of acquired resistance to thyroid hormone may occur in the general population. Its clinical significance remains largely unknown. The objective of the study was to explore whether a newly described thyroid hormone resistance index is associated with the risk of mortality in a sample of community-dwelling euthyroid subjects representative of the adult population of Spain. DESIGN Longitudinal observational study including 3750 individuals, free of thyroid disease, TPO antibodies-negative (<50 IU/mL) and with TSH levels within the euthyroid range (≥0.5 and ≤5.0 mUI/mL) participating in the nationwide study Di@bet.es (2008-2010). METHODS We used the Thyroid Feedback Quantile-based Index (TFQI) as a marker of resistance to thyroid hormone. The study population was grouped into categories according to their TFQI values at baseline. Fatal events were ascertained from the national death registry (end of follow-up December 2016). RESULTS A total of 231 deaths were recorded during an average follow-up of 7.3 years. Compared with the category with the highest sensitivity to free thyroxine (TFQI ≤ p5) (reference), the relative risk of mortality in the categories with TFQI > p5 and ≤p25; >p25 and ≤p50; >p50 and ≤p75; >p75 and ≤p95 and >p95 were 1.01, (0.47-2.19), 1.42 (0.68-2.97), 1.54 (0.74-3.22), 1.47 (0.70-3.11) and 2.61 (1.16-5.89), respectively (P for trend 0.003). The association remained significant after multivariate adjustment of the data (P for trend 0.017). CONCLUSIONS A thyroid hormone resistance index focused on deviations of the average pituitary response to thyroid hormones may be associated with all-cause mortality independently of other conventional risk factors and comorbidities.
Collapse
Affiliation(s)
- Silvia Patricia Alonso
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
| | - Sergio Valdés
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Cristina Maldonado-Araque
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Ana Lago
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Pilar Ocon
- UGC de Laboratorio (Bioquímica), Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
| | - Alfonso Calle
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario S. Carlos de Madrid, Madrid, Spain
| | - Luis Castaño
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Hospital Universitario Cruces, BioCruces Bizkaia, UPV/EHU, Barakaldo, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
| | - Elías Delgado
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias/University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
| | - Edelmiro Menéndez
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias/University of Oviedo, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain
| | - Josep Franch-Nadal
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- EAP Raval Sud, Institut Català de la Salut, Red GEDAPS, Primary Care, Unitat de Suport a la Recerca (IDIAP - Fundació Jordi Gol), Barcelona, Spain
| | - Sonia Gaztambide
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario Cruces - BioCruces Bizkaia - UPV-EHU, Baracaldo, Barcelona, Spain
| | - Juan Girbés
- Diabetes Unit, Hospital Arnau de Vilanova, Valencia, Spain
| | - Felipe Chaves
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Genomic Studies and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia-INCLIVA, Valencia, Spain
| | - Sara Garcia-Serrano
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Eva Garcia-Escobar
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - José Carlos Fernandez-García
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
| | - Gabriel Olveira
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Natalia Colomo
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Gemma Rojo-Martínez
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga/Universidad de Málaga, Instituto de Investigación Biomedica de Málaga-IBIMA, Málaga, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|
2
|
Fontalba-Romero MI, López-Enriquez S, Lago-Sampedro A, Garcia-Escobar E, Pastori RL, Domínguez-Bendala J, Alvarez-Cubela S, Valdés S, Rojo-Martinez G, García-Fuentes E, Labajos-Manzanares MT, García-Serrano S. Association between the Mediterranean Diet and Metabolic Syndrome with Serum Levels of miRNA in Morbid Obesity. Nutrients 2021; 13:nu13020436. [PMID: 33572759 PMCID: PMC7911421 DOI: 10.3390/nu13020436] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2020] [Revised: 01/21/2021] [Accepted: 01/25/2021] [Indexed: 12/17/2022] Open
Abstract
Background: The Mediterranean diet (MD) could be involved in the regulation of different miRNAs related to metabolic syndrome (MS). Methods: We analyzed the serum level of mir-let7a-5p, mir-21, mir-590, mir-107 and mir-192 in patients with morbid obesity and its association with the MD and MS. Results: There is an association between the adherence to MD and higher serum levels of mir-590. Mir-590 was lower in those patients who consumed >2 commercial pastries/week. Mir-let7a was lower in those who consumed ≥1 sweetened drinks, in those who consumed ≥3 pieces of fruit/day and in those who consumed less red than white meat. A lower mir-590 and mir-let7a, and a higher mir-192 level, were found in patients who met the high-density lipoprotein cholesterol (HDL) criterion of MS. A higher mir-192 was found in those patients who met the triglyceride criterion of MS and in those with type 2 diabetes (T2DM). Conclusions: There is an association between specific serum levels of miRNAs and the amount and kind of food intake related to MD. Mir-590 was positively associated with a healthy metabolic profile and type of diet, while mir-192 was positively associated with a worse metabolic profile. These associations could be suggestive of a possible modulation of these miRNAs by food.
Collapse
Affiliation(s)
- María I. Fontalba-Romero
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario, 29010 Málaga, Spain; (M.I.F.-R.); (A.L.-S.); (E.G.-E.); (S.V.); (S.G.-S.)
| | - Soledad López-Enriquez
- Departamento de Bioquímica Médica, Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Sevilla, 41009 Sevilla, Spain;
- Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain
| | - Ana Lago-Sampedro
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario, 29010 Málaga, Spain; (M.I.F.-R.); (A.L.-S.); (E.G.-E.); (S.V.); (S.G.-S.)
- Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain
| | - Eva Garcia-Escobar
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario, 29010 Málaga, Spain; (M.I.F.-R.); (A.L.-S.); (E.G.-E.); (S.V.); (S.G.-S.)
- Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), 29009 Málaga, Spain
| | - Ricardo L. Pastori
- Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA; (R.L.P.); (J.D.-B.); (S.A.-C.)
| | - Juan Domínguez-Bendala
- Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA; (R.L.P.); (J.D.-B.); (S.A.-C.)
| | - Silvia Alvarez-Cubela
- Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA; (R.L.P.); (J.D.-B.); (S.A.-C.)
| | - Sergio Valdés
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario, 29010 Málaga, Spain; (M.I.F.-R.); (A.L.-S.); (E.G.-E.); (S.V.); (S.G.-S.)
- Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), 29009 Málaga, Spain
| | - Gemma Rojo-Martinez
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario, 29010 Málaga, Spain; (M.I.F.-R.); (A.L.-S.); (E.G.-E.); (S.V.); (S.G.-S.)
- Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), 29009 Málaga, Spain
- Correspondence: (G.R.-M); (E.G.-F.)
| | - Eduardo García-Fuentes
- Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain
- Unidad de Gestión Clínica de Aparato Digestivo, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain
- Correspondence: (G.R.-M); (E.G.-F.)
| | | | - Sara García-Serrano
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Regional Universitario, 29010 Málaga, Spain; (M.I.F.-R.); (A.L.-S.); (E.G.-E.); (S.V.); (S.G.-S.)
- Instituto de Investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), 29009 Málaga, Spain
| |
Collapse
|
3
|
Valdés S, Maldonado-Araque C, Lago-Sampedro A, Lillo-Muñoz JA, Garcia-Fuentes E, Perez-Valero V, Gutiérrez-Repiso C, Garcia-Escobar E, Goday A, Urrutia I, Peláez L, Calle-Pascual A, Bordiú E, Castaño L, Castell C, Delgado E, Menéndez E, Franch-Nadal J, Gaztambide S, Girbés J, Ortega E, Vendrell J, Chacón MR, Javier Chaves F, Soriguer F, Rojo-Martínez G. Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study. Obesity (Silver Spring) 2017; 25:788-793. [PMID: 28276648 DOI: 10.1002/oby.21796] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2016] [Revised: 12/22/2016] [Accepted: 01/12/2017] [Indexed: 01/09/2023]
Abstract
OBJECTIVE To analyze the reference range of thyroid-stimulating hormone (TSH) in different BMI categories and its impact on the classification of hypothyroidism. METHODS The study included 3,928 individuals free of thyroid disease (without previous thyroid disease, no interfering medications, TSH <10 µUI/mL and thyroid peroxidase antibodies [TPO Abs] <50 IU/mL) who participated in a national, cross-sectional, population-based study and were representative of the adult population of Spain. Data gathered included clinical and demographic characteristics, physical examination, and blood and urine sampling. TSH, free thyroxine, free triiodothyronine, and TPO Ab were analyzed by electrochemiluminescence (E170, Roche Diagnostics, Basel, Switzerland). RESULTS The reference range (p2.5-97.5) for TSH was estimated as 0.6 to 4.8 µUI/mL in the underweight category (BMI<20 kg/m2 ), 0.6 to 5.5 µUI/mL in the normal-weight category (BMI 20-24.9 kg/m2 ), 0.6 to 5.5 µUI/mL in the overweight category (BMI 25-29.9 kg/m2 ), 0.5 to 5.9 µUI/mL in the obesity category (BMI 30-39.9 kg/m2 ), and 0.7 to 7.5 µUI/mL in the morbid obesity category (BMI ≥40). By using the reference criteria for the normal-weight population, the prevalence of high TSH levels increased threefold in the morbid obesity category (P < 0.01). CONCLUSIONS Persons with morbid obesity might be inappropriately classified if the standard ranges of normality of TSH for the normal-weight population are applied to them.
Collapse
Affiliation(s)
- Sergio Valdés
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| | - Cristina Maldonado-Araque
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| | - Ana Lago-Sampedro
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| | | | - Eduardo Garcia-Fuentes
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
- CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
| | - Vidal Perez-Valero
- UGC de Laboratorio (Bioquímica), Hospital Regional Universitario de Málaga, Málaga, Spain
| | - Carolina Gutiérrez-Repiso
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| | - Eva Garcia-Escobar
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| | - Albert Goday
- Department of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain
| | - Inés Urrutia
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Hospital Universitario Cruces, BioCruces, UPV/EHU, Barakaldo, Spain
| | - Laura Peláez
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| | - Alfonso Calle-Pascual
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario S. Carlos de Madrid, Spain
| | - Elena Bordiú
- Laboratorio de Bioquímica, Hospital Universitario S. Carlos de Madrid, Spain
| | - Luis Castaño
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Hospital Universitario Cruces, BioCruces, UPV/EHU, Barakaldo, Spain
| | - Conxa Castell
- Public Health Agency, Department of Health, Autonomous Government of Catalonia, Barcelona, Spain
| | - Elias Delgado
- Department of Endocrinology and Nutrition, Hospital Central de Asturias, Oviedo, Spain
| | - Edelmiro Menéndez
- Department of Endocrinology and Nutrition, Hospital Central de Asturias, Oviedo, Spain
| | - Josep Franch-Nadal
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- EAP Raval Sud, Institut Català de la Salut, Red GEDAPS, Primary Care, Unitat de Suport a la Recerca (IDIAP - Fundació Jordi Gol), Barcelona, Spain
| | - Sonia Gaztambide
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario Cruces - UPV-EHU, Baracaldo, Spain
| | - Joan Girbés
- Diabetes Unit, Hospital Arnau de Vilanova, Valencia, Spain
| | - Emilio Ortega
- CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Spain
| | - Joan Vendrell
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario Joan XXIII, Institut d'Investigacions Sanitaries Pere Virgili, Tarragona, Spain
| | - Matilde R Chacón
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Universitario Joan XXIII, Institut d'Investigacions Sanitaries Pere Virgili, Tarragona, Spain
| | - F Javier Chaves
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Genotyping and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia-INCLIVA, Valencia, Spain
| | - Federico Soriguer
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| | - Gemma Rojo-Martínez
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA, Málaga, Spain
| |
Collapse
|
4
|
Garcia-Serrano S, Gutiérrez-Repiso C, Gonzalo M, Garcia-Arnes J, Valdes S, Soriguer F, Perez-Valero V, Alaminos-Castillo MA, Francisco Cobos-Bravo J, Moreno-Ruiz FJ, Rodriguez-Cañete A, Rodríguez-Pacheco F, Garcia-Escobar E, García-Fuentes E. C-peptide modifies leptin and visfatin secretion in human adipose tissue. Obesity (Silver Spring) 2015; 23:1607-15. [PMID: 26146822 DOI: 10.1002/oby.21137] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/15/2014] [Revised: 02/24/2015] [Accepted: 03/29/2015] [Indexed: 12/17/2022]
Abstract
OBJECTIVE The effects of C-peptide on adipose tissue, an organ involved in the development of obesity and insulin resistance, are not yet well known. The aim of this study was to determine whether C-peptide could be involved in the regulation of the adipocytokine synthesis in human visceral adipose tissue. METHODS The association between C-peptide and different serum adipocytokines, with an intravenous glucose tolerance test (IVGTT), and in an in vitro study in subjects without obesity and in subjects with morbid obesity were analyzed. RESULTS In different multiple regression analysis models, C-peptide and C-peptide increase above basal levels during total IVGTT and between 0 and 10 min were associated positively with leptin and negatively with visfatin. Rhodamine-labeled C-peptide binds to human adipocytes, and this binding was blocked with excess of unlabeled C-peptide. Exposure of human visceral explants and adipocytes from subjects with morbid obesity to C-peptide at 1 and 10 nM induced a significant increase in leptin and a decrease in visfatin secretion. In subjects without obesity, these C-peptide effects were found mainly at 10 nM. These effects can be inhibited by phosphatidylinositol 3-kinase (PI3K) or protein kinase B (PKB) inhibitors. CONCLUSIONS C-peptide may be involved in the regulation of leptin and visfatin secretion, molecules intimately involved in energy homeostasis processes, through PI3K or PKB pathways.
Collapse
Affiliation(s)
- Sara Garcia-Serrano
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
- CIBER De Diabetes Y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Carolina Gutiérrez-Repiso
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Montserrat Gonzalo
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Juan Garcia-Arnes
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Sergio Valdes
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
- CIBER De Diabetes Y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Federico Soriguer
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
- CIBER De Diabetes Y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
- CIBER Fisiopatología De La Obesidad Y Nutrición (CIBEROBN), Málaga, Spain
| | - Vidal Perez-Valero
- Unidad De Gestión Clínica De Laboratorio, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Miguel A Alaminos-Castillo
- Unidad De Gestión Clínica De Laboratorio, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Juan Francisco Cobos-Bravo
- Unidad De Gestión Clínica De Cirugía General, Digestiva Y Trasplantes, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Francisco J Moreno-Ruiz
- Unidad De Gestión Clínica De Cirugía General, Digestiva Y Trasplantes, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Alberto Rodriguez-Cañete
- Unidad De Gestión Clínica De Cirugía General, Digestiva Y Trasplantes, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | - Francisca Rodríguez-Pacheco
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
- CIBER De Diabetes Y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Eva Garcia-Escobar
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
- CIBER De Diabetes Y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Eduardo García-Fuentes
- Unidad De Gestión Clínica De Endocrinología Y Nutrición, Instituto De Investigacion Biomédica De Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
- CIBER Fisiopatología De La Obesidad Y Nutrición (CIBEROBN), Málaga, Spain
| |
Collapse
|
5
|
Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, Garcia-Escobar E, Haro-Mora JJ, Garcia-Arnes J, Valdes S, Gonzalo M, Soriguer F, Moreno-Ruiz FJ, Rodriguez-Cañete A, Martinez-Ferriz A, Santoyo JS, Perez-Valero V, Garcia-Fuentes E. FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest 2014; 44:918-25. [PMID: 25112714 DOI: 10.1111/eci.12324] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/16/2013] [Accepted: 08/06/2014] [Indexed: 12/17/2022]
Abstract
INTRODUCTION Irisin activates the thermogenic function in adipose tissues. However, little is known on the association between human irisin and different cardiometabolic risk factors. We analyse the influence of morbid obesity on irisin levels and its relation with leptin and different cardiovascular risk factors. MATERIAL AND METHODS We measured the serum irisin level and the fibronectin type III domain containing 5 (FNDC5) expression in adipose tissue from 33 morbidly obese subjects and 12 nonobese subjects. We also studied the effect of leptin on FNDC5 expression. RESULTS Serum irisin was higher in the nonobese subjects than in morbidly obese subjects, both before (P = 0·043) and after bariatric surgery (P = 0·042). The variable that best explained the serum irisin levels in a multiple linear regression model was the waist-to-hip ratio (WHR) (R(2) = 0·201) (Beta = -0·357, P = 0·046). Those morbidly obese subjects with android-type obesity had lower serum irisin levels than those with gynecoid-type obesity, both before (P = 0·027) and after bariatric surgery (P = 0·006). Only the percentage change in WHR was associated with serum irisin levels after bariatric surgery (r = -0·529, P = 0·005). FNDC5 expression levels in subcutaneous adipose tissue (SAT) were higher in the nonobese than in the morbidly obese subjects (P = 0·042). In SAT explants from nonobese subjects, leptin (20 and 150 ng/mL) produced a decrease in FNDC5 expression (P = 0·009 and P = 0·037, respectively). CONCLUSIONS We showed decreased serum irisin levels in morbidly obese subjects, related mainly to WHR. FNDC5 expression could be regulated by leptin.
Collapse
Affiliation(s)
- Carolina Gutierrez-Repiso
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Rodriguez-Pacheco F, Garcia-Serrano S, Garcia-Escobar E, Gutierrez-Repiso C, Garcia-Arnes J, Valdes S, Gonzalo M, Soriguer F, Moreno-Ruiz FJ, Rodriguez-Cañete A, Gallego-Perales JL, Martinez-Ferriz A, Rojo-Martínez G, Garcia-Fuentes E. Effects of obesity/fatty acids on the expression of GPR120. Mol Nutr Food Res 2014; 58:1852-60. [DOI: 10.1002/mnfr.201300666] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2013] [Revised: 02/10/2014] [Accepted: 04/02/2014] [Indexed: 01/28/2023]
Affiliation(s)
- Francisca Rodriguez-Pacheco
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
- CIBERDEM, Instituto de Salud Carlos III; Malaga Spain
| | - Sara Garcia-Serrano
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
- CIBERDEM, Instituto de Salud Carlos III; Malaga Spain
| | - Eva Garcia-Escobar
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
- CIBERDEM, Instituto de Salud Carlos III; Malaga Spain
| | - Carolina Gutierrez-Repiso
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
| | - Juan Garcia-Arnes
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
| | - Sergio Valdes
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
- CIBERDEM, Instituto de Salud Carlos III; Malaga Spain
| | - Montserrat Gonzalo
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
| | - Federico Soriguer
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
- CIBERDEM, Instituto de Salud Carlos III; Malaga Spain
- CIBEROBN; Instituto de Salud Carlos III; Malaga Spain
| | - Francisco J. Moreno-Ruiz
- Unidad de Gestion Clínica de Cirugía General; Digestiva y Trasplantes; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
| | - Alberto Rodriguez-Cañete
- Unidad de Gestion Clínica de Cirugía General; Digestiva y Trasplantes; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
| | - Jose L. Gallego-Perales
- Unidad de Gestion Clínica de Cirugía General; Digestiva y Trasplantes; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
| | - Abelardo Martinez-Ferriz
- Unidad de Gestion Clínica de Cirugía General; Digestiva y Trasplantes; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
| | - Gemma Rojo-Martínez
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
- CIBERDEM, Instituto de Salud Carlos III; Malaga Spain
- CIBEROBN; Instituto de Salud Carlos III; Malaga Spain
| | - Eduardo Garcia-Fuentes
- Unidad de Gestion Clinica de Endocrinogía y Nutrición; Instituto de Investigaciones Biomédicas de Málaga (IBIMA); Hospital Regional Universitario; Malaga Spain
- CIBERDEM, Instituto de Salud Carlos III; Malaga Spain
- CIBEROBN; Instituto de Salud Carlos III; Malaga Spain
| |
Collapse
|
7
|
Gutiérrez-Repiso C, Velasco I, Garcia-Escobar E, Garcia-Serrano S, Rodríguez-Pacheco F, Linares F, Ruiz de Adana MS, Rubio-Martin E, Garrido-Sanchez L, Cobos-Bravo JF, Priego-Puga T, Rojo-Martinez G, Soriguer F, García-Fuentes E. Does dietary iodine regulate oxidative stress and adiponectin levels in human breast milk? Antioxid Redox Signal 2014; 20:847-53. [PMID: 24001137 PMCID: PMC3910559 DOI: 10.1089/ars.2013.5554] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Little is known about the association between iodine and human milk composition. In this study, we investigated the association between iodine and different markers of oxidative stress and obesity-related hormones in human breast milk. This work is composed of two cross-sectional studies (in lactating women and in the general population), one prospective and one in vitro. In the cross-sectional study in lactating women, the breast milk iodine correlated negatively with superoxide dismutase (SOD), catalase, and glutathione peroxidase (GSH-Px) activities, and with adiponectin levels. An in vitro culture of human adipocytes with 1 μM potassium iodide (KI, dose similar to the human breast milk iodine concentration) produced a significant decrease in adiponectin, GSH-Px, SOD1, and SOD2 mRNA expression. However, after 2 months of treatment with KI in the prospective study, a positive correlation was found between 24-h urinary iodine and serum adiponectin. Our observations lead to the hypothesis that iodine may be a factor directly involved in the regulation of oxidative stress and adiponectin levels in human breast milk.
Collapse
Affiliation(s)
- Carolina Gutiérrez-Repiso
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Inés Velasco
- Unidad de Gestión Clínica Materno-Infantil, Hospital de Riotinto, Huelva, Spain
| | - Eva Garcia-Escobar
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Sara Garcia-Serrano
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Francisca Rodríguez-Pacheco
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Francisca Linares
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Maria Soledad Ruiz de Adana
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Elehazara Rubio-Martin
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Lourdes Garrido-Sanchez
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
- CIBER Fisiología de la Obesidad y Nutrición (CIBEROBN), Málaga, Spain
| | - Juan Francisco Cobos-Bravo
- Unidad de Gestión Clínica de Cirugia General, Digestiva y Transplantes, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
| | - Tatiana Priego-Puga
- Unidad de Gestión Clínica de Cirugia General, Digestiva y Transplantes, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
| | - Gemma Rojo-Martinez
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
| | - Federico Soriguer
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER de Diabetes y Enfermedades Metabólicas (CIBERDEM), Málaga, Spain
- CIBER Fisiología de la Obesidad y Nutrición (CIBEROBN), Málaga, Spain
| | - Eduardo García-Fuentes
- Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain
- CIBER Fisiología de la Obesidad y Nutrición (CIBEROBN), Málaga, Spain
| |
Collapse
|
8
|
Haro-Mora JJ, Garcia-Escobar E, Porras N, Alcazar D, Gaztambide J, Ruiz-Orpez A, Garcia-Serrano S, Gomez-Zumaquero JM, Garcia-Fuentes E, Lopez-Siguero JP, Soriguer F, Rojo-Martinez G. Adipose tissue characteristics related to weight z-score in childhood. Int J Endocrinol Metab 2013; 11:82-7. [PMID: 23825978 PMCID: PMC3693669 DOI: 10.5812/ijem.8744] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/23/2012] [Revised: 01/27/2013] [Accepted: 02/06/2013] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Childhood obesity has grown very fast over recent decades and now it represents a serious public health problem. The number of adipocytes is set in childhood and adolescence and then, an effective understanding of the development of adipose tissue during these periods will help in the prevention of this pathology. OBJECTIVES The current study aimed to determine which adipose tissue characteristics are related to a high weight Z-score in childhood. PATIENTS AND METHODS The current study included 82 children aged 5-130 months who underwent inguinal hernia surgery. Anthropometric variables were measured, and a nutritional and physical activity questionnaire was completed. Subcutaneous adipose tissue samples, taken during the operation, were analyzed for preadipocyte number, adipocyte volume, fatty acid composition (gas chromatography of FAME), and relative gene expression of various genes (real time PCR). RESULTS The results showed that children with a higher weight Z-score spend more time in sedentary activities and less time running or involved in active games. SCD-1 activity index, arachidonic/linoleic index, and adipocyte volume were significantly higher in children with a weight Z-score greater than 0. The preadipocyte number and the genetic expression of the studied genes did not differ between the groups. A multiple regression analysis was done to determine which variables were related to the weight Z-score. R2 values indicated that the model which included adipocyte volume, SREBP-1c, SCD-1 expression, and activity index, predicted 59% of the variability in the weight Z-score among the children. The main variables associated with adipocyte volume were PPARγ, Adiponectin, CB1R expressions, as well as the SCD-1 activity and normalized weight. CONCLUSIONS It was concluded that in childhood, the weight Z-score is related to adipocyte volume and adipose tissue gene expression.
Collapse
Affiliation(s)
- Juan Jesus Haro-Mora
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBERDEM, CB07/08/0019, Malaga, Spain
- Corresponding author: Juan Jesus Haro-Mora, Research Laboratory, Hall 5, basement. Civil Hospital, Civil Hospital Pl, 29009 Malaga, Spain, Tel.: +34-951290226, Fax: +34-952286704, E-mail:
| | - Eva Garcia-Escobar
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBERDEM, CB07/08/0019, Malaga, Spain
| | - Nuria Porras
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBERDEM, CB07/08/0019, Malaga, Spain
| | - Dolores Alcazar
- Maternal and Child Hospital of Malaga, Pediatric Surgery Department, Malaga, Spain
| | - Joaquin Gaztambide
- Maternal and Child Hospital of Malaga, Pediatric Surgery Department, Malaga, Spain
| | - Antonio Ruiz-Orpez
- Maternal and Child Hospital of Malaga, Pediatric Surgery Department, Malaga, Spain
| | - Sara Garcia-Serrano
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBERDEM, CB07/08/0019, Malaga, Spain
| | - Juan M. Gomez-Zumaquero
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBERDEM, CB07/08/0019, Malaga, Spain
| | - Eduardo Garcia-Fuentes
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBEROBN, CB06/03/0060 Malaga, Spain
| | - Juan P Lopez-Siguero
- Maternal and Child Hospital of Malaga, Pediatric endocrinology Department, Malaga, Spain
| | - Federico Soriguer
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBERDEM, CB07/08/0019, Malaga, Spain
| | - Gemma Rojo-Martinez
- Carlos Haya Hospital, Endocrinology and Nutrition Department, Research Laboratory, Malaga, Spain
- Health Institute Carlos III, CIBERDEM, CB07/08/0019, Malaga, Spain
| |
Collapse
|
9
|
Soriguer F, García-Serrano S, Garrido-Sánchez L, Gutierrez-Repiso C, Rojo-Martínez G, Garcia-Escobar E, García-Arnés J, Gallego-Perales JL, Delgado V, García-Fuentes E. Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus. J Lipid Res 2010; 51:3516-23. [PMID: 20855567 DOI: 10.1194/jlr.m007815] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The overproduction of intestinal lipoproteins may contribute to the dyslipidemia found in diabetes. We studied the influence of diabetes on the fasting jejunal lipid content and its association with plasma lipids and the expression of genes involved in the synthesis and secretion of these lipoproteins. The study was undertaken in 27 morbidly obese persons, 12 of whom had type 2 diabetes mellitus (T2DM). The morbidly obese persons with diabetes had higher levels of chylomicron (CM) triglycerides (P < 0.001) and apolipoprotein (apo)B48 (P = 0.012). The jejunum samples obtained from the subjects with diabetes had a lower jejunal triglyceride content (P = 0.012) and angiopoietin-like protein 4 (ANGPTL4) mRNA expression (P = 0.043). However, the apoA-IV mRNA expression was significantly greater (P = 0.036). The jejunal triglyceride content correlated negatively with apoA-IV mRNA expression (r = -0.587, P = 0.027). The variables that explained the jejunal triglyceride content in a multiple linear regression model were the insulin resistance state and the apoA-IV mRNA expression. Our results show that the morbidly obese subjects with diabetes had lower jejunal lipid content and that this correlated negatively with apoA-IV mRNA expression. These findings show that the jejunum appears to play an active role in lipid homeostasis in the fasting state.
Collapse
Affiliation(s)
- F Soriguer
- Servicios de Endocrinología y Nutrición y Cirugía General, Málaga, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Olveira G, Olveira C, Casado-Miranda E, Padilla A, Dorado A, Rojo-Martinez G, Porras N, Garcia-Escobar E, Soriguer F. Markers for the Validation of Reported Dietary Intake in Adults with Cystic Fibrosis. ACTA ACUST UNITED AC 2009; 109:1704-11. [DOI: 10.1016/j.jada.2009.07.012] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2008] [Accepted: 04/17/2009] [Indexed: 01/27/2023]
|